Factor | N = 2601 |
---|---|
Socio-demographic and study characteristics | |
Median age (IQR) | 40.5 (34.5, 47.1) |
Race/ethnicity | |
 African American, non-Hispanic | 1632 (63) |
 Latina/Hispanic | 574 (22) |
 White, non-Hispanic | 317 (12) |
 Asian/Pacific Islander/Native American or Alaskan/Other | 78 (3) |
Enrollment wave | |
 Wave 1: 1994–1995 | 1230 (47) |
 Wave 2: 2001–2002 | 617 (24) |
 Wave 3: 2011–2012 | 230 (8) |
 Wave 4: 2013–2015 | 524 (20) |
Less than high school education | 949 (36) |
Married or partnered | 863 (33) |
Unstable housing | 140 (5) |
Unemployed | 1754 (67) |
Annual household income ≤$24,000 | 2057 (79) |
No health insurance | 241 (9) |
Pregnant in past 6 months | 114 (4) |
Mental Health | |
Depressive symptoms (CES-D score ≥ 16) | 1043 (40) |
Substance Use | |
Current smoker | 1196 (46) |
Alcohol use | |
 None | 1401 (54) |
 Low (> 0–7 drinks per week) | 965 (37) |
 Moderate (> 7–12 drinks per week) | 97 (4) |
 Heavy (> 12 drinks per week) | 138 (5) |
Non-injection drug use | 617 (24) |
Injection drug use | |
 Never | 2018 (78) |
 Former | 528 (20) |
 Current | 55 (2) |
Medical injection experience | |
 Insulin use (medical injection) | |
  Never | 2525 (97) |
  Former | 15 (1) |
  Current | 61 (2) |
 Depo medroxyprogesterone acetate use (medical injection) | |
  Never | 2300 (88) |
  Former | 156 (6) |
  Current | 145 (6) |
Adherence and viral suppression | |
  ≥ 75% adherence reported | 2135 (82) |
 HIV RNA ≤80 copies/ml | 1370 (53) |